tiprankstipranks
Trending News
More News >
Recordati Industria Chimica e Farmaceutica SPA (GB:0KBS)
LSE:0KBS
UK Market
Advertisement

Recordati Industria Chimica e Farmaceutica SPA (0KBS) Ratios

Compare
0 Followers

Recordati Industria Chimica e Farmaceutica SPA Ratios

GB:0KBS's free cash flow for Q2 2025 was €0.66. For the 2025 fiscal year, GB:0KBS's free cash flow was decreased by € and operating cash flow was €0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.47 1.20 1.28 1.36 1.34
Quick Ratio
1.01 0.79 0.82 0.99 0.90
Cash Ratio
0.32 0.22 0.31 0.39 0.33
Solvency Ratio
0.18 0.21 0.18 0.34 0.31
Operating Cash Flow Ratio
0.54 0.48 0.50 0.78 0.70
Short-Term Operating Cash Flow Coverage
7.11 4.86 1.21 2.12 1.43
Net Current Asset Value
€ -1.74B€ -1.32B€ -1.27B€ -584.47M€ -662.44M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.43 0.43 0.35 0.39
Debt-to-Equity Ratio
0.04 1.07 1.11 0.72 0.83
Debt-to-Capital Ratio
0.04 0.52 0.53 0.42 0.45
Long-Term Debt-to-Capital Ratio
0.00 0.44 0.46 0.35 0.37
Financial Leverage Ratio
2.77 2.50 2.59 2.04 2.13
Debt Service Coverage Ratio
3.99 3.48 1.13 2.01 1.55
Interest Coverage Ratio
6.94 7.49 13.60 28.14 26.80
Debt to Market Cap
<0.01 0.14 0.21 0.08 0.11
Interest Debt Per Share
0.83 9.16 8.51 4.90 5.24
Net Debt to EBITDA
-0.32 2.24 2.56 1.29 1.54
Profitability Margins
Gross Profit Margin
67.79%68.32%69.42%72.93%71.92%
EBIT Margin
25.43%27.16%23.40%30.43%32.66%
EBITDA Margin
33.02%34.01%30.18%36.60%39.12%
Operating Profit Margin
25.46%26.80%23.60%31.02%32.37%
Pretax Profit Margin
21.77%23.58%21.66%29.32%31.45%
Net Profit Margin
16.42%18.69%16.85%24.43%24.50%
Continuous Operations Profit Margin
16.42%18.69%16.85%24.43%24.50%
Net Income Per EBT
75.45%79.26%77.80%83.30%77.91%
EBT Per EBIT
85.50%88.00%91.79%94.52%97.15%
Return on Assets (ROA)
7.87%9.25%7.81%13.71%13.09%
Return on Equity (ROE)
21.43%23.08%20.20%27.94%27.82%
Return on Capital Employed (ROCE)
15.37%17.41%14.22%22.39%21.99%
Return on Invested Capital (ROIC)
11.37%13.34%9.81%16.86%15.13%
Return on Tangible Assets
21.11%26.09%21.38%34.33%34.34%
Earnings Yield
3.87%3.86%3.92%3.32%3.81%
Efficiency Ratios
Receivables Turnover
3.54 4.68 5.12 5.13 5.39
Payables Turnover
2.42 2.50 2.52 2.40 3.08
Inventory Turnover
1.62 1.63 1.34 1.87 1.62
Fixed Asset Turnover
11.99 11.66 11.64 12.05 10.87
Asset Turnover
0.48 0.49 0.46 0.56 0.53
Working Capital Turnover Ratio
4.59 9.02 7.63 7.56 6.95
Cash Conversion Cycle
177.75 155.97 199.68 114.45 174.64
Days of Sales Outstanding
103.07 78.04 71.27 71.10 67.74
Days of Inventory Outstanding
225.61 223.98 273.12 195.19 225.42
Days of Payables Outstanding
150.92 146.05 144.72 151.83 118.51
Operating Cycle
328.67 302.02 344.40 266.29 293.16
Cash Flow Ratios
Operating Cash Flow Per Share
2.77 2.36 2.25 2.39 1.96
Free Cash Flow Per Share
2.41 0.50 1.78 1.96 1.32
CapEx Per Share
0.36 1.86 0.47 0.42 0.64
Free Cash Flow to Operating Cash Flow
0.87 0.21 0.79 0.82 0.67
Dividend Paid and CapEx Coverage Ratio
1.70 0.77 1.41 1.62 1.17
Capital Expenditure Coverage Ratio
7.69 1.27 4.79 5.63 3.06
Operating Cash Flow Coverage Ratio
7.11 0.27 0.27 0.50 0.38
Operating Cash Flow to Sales Ratio
0.23 0.23 0.25 0.31 0.28
Free Cash Flow Yield
4.79%1.01%4.59%3.47%2.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.85 25.89 25.51 30.16 26.27
Price-to-Sales (P/S) Ratio
4.21 4.84 4.30 7.37 6.44
Price-to-Book (P/B) Ratio
5.63 5.97 5.15 8.42 7.31
Price-to-Free Cash Flow (P/FCF) Ratio
20.88 98.73 21.80 28.79 34.30
Price-to-Operating Cash Flow Ratio
18.31 20.76 17.25 23.67 23.11
Price-to-Earnings Growth (PEG) Ratio
-1.07 1.06 -1.36 3.73 -6.76
Price-to-Fair Value
5.63 5.97 5.15 8.42 7.31
Enterprise Value Multiple
12.43 16.47 16.80 21.42 17.99
Enterprise Value
10.18B 11.66B 9.40B 12.39B 10.20B
EV to EBITDA
12.43 16.47 16.80 21.42 17.99
EV to Sales
4.11 5.60 5.07 7.84 7.04
EV to Free Cash Flow
20.36 114.28 25.72 30.64 37.51
EV to Operating Cash Flow
17.71 24.03 20.36 25.20 25.27
Tangible Book Value Per Share
-6.64 -5.01 -4.83 -1.51 -1.95
Shareholders’ Equity Per Share
9.03 8.20 7.52 6.71 6.20
Tax and Other Ratios
Effective Tax Rate
0.25 0.21 0.22 0.17 0.22
Revenue Per Share
11.96 10.13 9.01 7.67 7.04
Net Income Per Share
1.96 1.89 1.52 1.87 1.73
Tax Burden
0.75 0.79 0.78 0.83 0.78
Interest Burden
0.86 0.87 0.93 0.96 0.96
Research & Development to Revenue
0.13 0.12 0.12 0.11 0.10
SG&A to Revenue
0.07 0.06 0.06 0.05 0.05
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.41 1.25 1.48 1.27 1.14
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis